Zenex Animal Health India Pvt Ltd, formed after private equity firm Multiples PE and a consortium of investors acquired ...

Our Bureau, Mumbai Thursday, January 30, 2025, 17:40 Hrs [IST] ...

Other PBC candidates coming through the collective industry pipeline include CymaBay's seladelpar and Zydus Cadila's saroglitazar - both PPAR agonists – as well as Genkyotex' NOX 1 and 4 ...

Several copycat versions of the drug have already been approved, including from Zydus Cadila and Lupin Labs. However, given Astellas’ plan to elevate the case to the Court of Appeals for the ...

Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited) is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value ...

Zydus Life share rose after it received approval from USFDA to conduct Phase II(b) clinical trial for Usnoflast, a novel oral NLRP3 inflammasome inhibitor in patients with ALS ...

Herpes Labialis Treatment Market. The global herpes labialis treatment market is on track for substantial growth, with a projected Compound Annual Growth Rate (CAGR) of 4.7% from ...

Anti-Fungal Therapy Market. The global anti-fungal therapy market is set to experience significant growth, with a projected ...

Alzheimer’s Therapeutics MarketThe global Alzheimer’s therapeutics market is projected to experience significant growth, with an expected valuation of USD 3,052.3 million in 2023. The market is ...

Zydus Lifesciences Ltd. key Products/Revenue Segments include ... As on 31-12-2024, the company has a total of 100.62 Crore shares outstanding.Cadila Healthcare Share Price Today is Rs. 994.15. On ...

Pharma stocks tumbled as the Nifty Pharma index dropped two percent, with Alkem, Ipca, and Divi’s Labs leading losses.